Highly selective norepinephrine reuptake inhibitors and methods of using the same

摘要

The invention provides the use of optically pure (S,S)-reboxetine, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of attention deficit (or other cognitive disorders) due to general medical conditions.